CTV News Channel with Dr. Sharon Cohen on FDA approval of aducanumab 6 8 2021

Dr. Sharon Cohen, Medical Director and Principal Investigator at Toronto Memory Program discusses the exciting news that FDA has approved the use of aducanumab. The first new treatment for Alzheimer's disease in 20 years and the very first disease-modifying drug proven to slow AD progression.

[@aham1082]

Good day, please tell me how and where I can get information. Will a doctor in Canada be able to prescribe my wife a medicine with a specific name Depakine Chrono 500 mg. She can only take this medicine.
We are currently in Russia, but we are planning to immigrate to Canada.